LCP
Legacy Capital Partners’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $3.15M | Sell |
41,252
-200
| -0.5% | -$15.3K | 1.04% | 30 |
|
2021
Q4 | $2.49M | Sell |
41,452
-228
| -0.5% | -$13.7K | 0.81% | 40 |
|
2021
Q3 | $2.33M | Sell |
41,680
-71
| -0.2% | -$3.98K | 0.84% | 40 |
|
2021
Q2 | $2.53M | Sell |
41,751
-200
| -0.5% | -$12.1K | 0.91% | 35 |
|
2021
Q1 | $2.94M | Hold |
41,951
| – | – | 1.11% | 28 |
|
2020
Q4 | $2.51M | Sell |
41,951
-1,400
| -3% | -$83.8K | 0.98% | 32 |
|
2020
Q3 | $2.61M | Sell |
43,351
-200
| -0.5% | -$12K | 1.05% | 33 |
|
2020
Q2 | $2.29M | Sell |
43,551
-130
| -0.3% | -$6.82K | 0.98% | 36 |
|
2020
Q1 | $1.47M | Sell |
43,681
-164
| -0.4% | -$5.5K | 0.73% | 43 |
|
2019
Q4 | $1.99M | Sell |
43,845
-700
| -2% | -$31.7K | 0.8% | 44 |
|
2019
Q3 | $1.7M | Sell |
44,545
-4,028
| -8% | -$153K | 0.74% | 46 |
|
2019
Q2 | $2.11M | Buy |
48,573
+1,025
| +2% | +$44.6K | 0.94% | 42 |
|
2019
Q1 | $1.81M | Sell |
47,548
-460
| -1% | -$17.5K | 0.84% | 43 |
|
2018
Q4 | $2.07M | Buy |
48,008
+475
| +1% | +$20.4K | 1.09% | 36 |
|
2018
Q3 | $2.34M | Sell |
47,533
-1,055
| -2% | -$51.8K | 1.08% | 35 |
|
2018
Q2 | $1.56M | Sell |
48,588
-800
| -2% | -$25.6K | 0.76% | 49 |
|
2018
Q1 | $1.54M | Sell |
49,388
-1,105
| -2% | -$34.4K | 0.77% | 49 |
|
2017
Q4 | $2.31M | Buy |
50,493
+3,100
| +7% | +$142K | 1.14% | 38 |
|
2017
Q3 | $1.78M | Buy |
47,393
+600
| +1% | +$22.5K | 0.94% | 43 |
|
2017
Q2 | $2.23M | Buy |
46,793
+3,045
| +7% | +$145K | 1.21% | 33 |
|
2017
Q1 | $2M | Buy |
43,748
+3,695
| +9% | +$169K | 1.12% | 38 |
|
2016
Q4 | $1.29M | Buy |
40,053
+223
| +0.6% | +$7.21K | 0.78% | 47 |
|
2016
Q3 | $1.36M | Buy |
39,830
+16,630
| +72% | +$569K | 0.86% | 43 |
|
2016
Q2 | $783K | Buy |
23,200
+100
| +0.4% | +$3.38K | 0.49% | 61 |
|
2016
Q1 | $1.22M | Buy |
23,100
+3,050
| +15% | +$162K | 0.79% | 46 |
|
2015
Q4 | $1.54M | Sell |
20,050
-600
| -3% | -$46.1K | 0.99% | 37 |
|
2015
Q3 | $849K | Buy |
+20,650
| New | +$849K | 0.58% | 59 |
|